Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy

被引:7
|
作者
Saliba, Antoine N. [1 ,2 ]
Xie, Zhuoer [1 ,2 ]
Higgins, Alexandra S. [1 ,2 ]
Andrade-Gonzalez, Xavier A. [1 ,2 ]
Fuentes-Bayne, Harry E. [1 ,2 ]
Hampel, Paul J. [1 ,2 ]
Kankeu Fonkoua, Lionel A. [1 ,2 ]
Childs, Daniel S. [1 ,2 ]
Rakshit, Sagar [1 ,2 ]
Bezerra, Evandro D. [1 ,2 ]
Kommalapati, Anuhya [1 ,2 ]
Lou, Yanyan [3 ]
Rivera, Candido E. [3 ]
Price, Katharine A. [2 ]
Chintakuntlawar, Ashish [2 ]
Yan, Yiyi [2 ]
Schwecke, Anna J. [2 ]
Block, Matthew S. [2 ]
Thanarajasingam, Uma [4 ]
Thanarajasingam, Gita [1 ]
Wolanskyj-Spinner, Alexandra P. [1 ]
Marshall, Ariela L. [1 ,5 ]
Kottschade, Lisa A. [2 ]
Go, Ronald S. [1 ]
Al-Kali, Aref [1 ]
机构
[1] Mayo Clin, Div Hematol, 200 1 St SW, Rochester, MN USA
[2] Mayo Clin, Dept Oncol, Div Med Oncol, Rochester, MN USA
[3] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL USA
[4] Mayo Clin, Div Rheumatol, Rochester, MN USA
[5] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
关键词
RITUXIMAB;
D O I
10.1002/ajh.26273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E362 / E367
页数:6
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
  • [42] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Daphne Day
    Aaron R. Hansen
    BioDrugs, 2016, 30 : 571 - 584
  • [43] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Day, Daphne
    Hansen, Aaron R.
    BIODRUGS, 2016, 30 (06) : 571 - 584
  • [44] AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Aude, C.
    Ghosh, N.
    Jannat-Khah, D.
    Chan, K. K.
    Postow, M.
    Larman, H.
    Bass, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1188 - 1189
  • [45] Immune signatures of treatment response and immune-related adverse events in melanoma patients under checkpoint inhibitor therapy
    Reschke, R.
    Gussek, P.
    Boldt, A.
    Sack, U.
    Koehl, U.
    Lordick, F.
    Kreuz, M.
    Reiche, K.
    Simon, J. C.
    Ziemer, M.
    Kunz, M.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E57 - E57
  • [46] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
    Schneider, Bryan J.
    Naidoo, Jarushka
    Santomasso, Bianca D.
    Lacchetti, Christina
    Adkins, Sherry
    Anadkat, Milan
    Atkins, Michael B.
    Brassil, Kelly J.
    Caterino, Jeffrey M.
    Chau, Ian
    Davies, Marianne J.
    Ernstoff, Marc S.
    Fecher, Leslie
    Ghosh, Monalisa
    Jaiyesimi, Ishmael
    Mammen, Jennifer S.
    Naing, Aung
    Nastoupil, Loretta J.
    Phillips, Tanyanika
    Porter, Laura D.
    Reichner, Cristina A.
    Seigel, Carole
    Song, Jung-Min
    Spira, Alexander
    Suarez-Almazor, Maria
    Swami, Umang
    Thompson, John A.
    Vikas, Praveen
    Wang, Yinghong
    Weber, Jeffrey S.
    Funchain, Pauline
    Bollin, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4073 - +
  • [47] Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
    Trinh, Saralinh
    Le, Alex
    Gowani, Sajida
    La-Beck, Ninh M.
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2019, 6 (02) : 154 - 160
  • [48] Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
    Duraisamy, Prasanna
    Panicker, Vinitha Varghese
    Jose, Wesley Mannirathil
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
  • [49] Survival Among Veterans Receiving Steroids for Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy
    Van Buren, Inga
    Madison, Cecelia
    Kohn, Aimee
    Berry, Elizabeth
    Kulkarni, Rajan P.
    Thompson, Reid F.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2340695
  • [50] Cutaneous immune-related adverse events from immune checkpoint inhibitor therapy: Moving beyond "maculopapular rash"
    Allais, Blair S.
    Fay, Christopher J.
    Kim, Daniel Y.
    Semenov, Yevgeniy R.
    LeBoeuf, Nicole R.
    IMMUNOLOGICAL REVIEWS, 2023, 318 (01) : 22 - 36